Heart disease kills approximately 160,000 people per year in the UK. 94% of bowel cancers occur over 50. Type 2 diabetes prevalence reaches 16% in over-65s. At 50, these risks are accelerating simultaneously. A comprehensive blood test like the TrueVitals Ultimate panel covers 114 biomarkers across cardiovascular, metabolic, hormonal, and cancer screening markers in a single draw. The NHS Health Check tests 4.
At 50, the NHS begins to take your health more seriously than at 40. Bowel cancer screening kits arrive every 2 years. Women receive breast screening mammograms every 3 years. Men can request a PSA test (but must proactively ask). The NHS Health Check continues every 5 years with its 3 to 4 blood markers. These are valuable. They are also incomplete.
Take every NHS screening when it's offered. It's free and it catches specific cancers early. Then layer a comprehensive blood test on top for the metabolic, hormonal, cardiovascular, and nutritional depth the NHS does not provide.
What makes 50 different from 40 is not any single risk. It's that multiple risks converge. Cardiovascular, metabolic, hormonal, thyroid, and cancer risks all increase simultaneously, and each one worsens the others. Testing them together reveals the interactions that isolated tests miss.
Heart disease kills approximately 160,000 people per year in the UK, more than any single cancer. By 50, decades of lipid accumulation, blood pressure, and metabolic stress have produced measurable arterial damage. For women, post-menopausal loss of oestrogen's cardiovascular protection means risk now equals men. ApoB (the protein that drives plaque formation) and Lp(a) (a genetically determined risk factor) are far more predictive than standard cholesterol but are not included in the NHS Health Check. If you have elevated Lp(a), you need to know by 50 at the latest. Cardiovascular blood test guide.
Type 2 diabetes prevalence reaches approximately 16% in over-65s, meaning the decade from 50 to 65 is when most cases develop. Fasting insulin and HOMA-IR detect the insulin resistance that precedes diagnosis by years. If you tested at 40 and your HOMA-IR was 1.5, retesting at 50 and finding it at 2.8 is a clear trend that warrants intervention now, not in 5 years when HbA1c finally flags it. Prediabetes blood test guide.
For men: testosterone has declined 25 to 35% from peak by 50. Free testosterone has declined even more. Fatigue, weight gain, low mood, poor recovery, and reduced libido are common. For women: most are in mid to late perimenopause or post-menopausal. Oestradiol has dropped significantly. The question at 50 is not whether hormones have changed. It's how much, and which specific interventions (HRT, testosterone, lifestyle, supplementation) are appropriate. That requires data. Low libido guide. Menopause guide.
12 to 20% of women over 60 have some degree of thyroid dysfunction. The process often begins in the 50s. Hashimoto's thyroiditis progresses gradually and can be active for years before TSH moves out of range. At 50, testing thyroid antibodies (Anti-TPO, Anti-Tg) catches autoimmune thyroid disease at the earliest stage. The NHS tests TSH only. Thyroid blood test guide.
PSA (prostate) should be tested in all men from 50 (earlier with family history or Black heritage). CA-125 (ovarian) has limitations but contributes to the overall screening picture in women. CEA and CA 19-9 provide gastrointestinal and pancreatic screening. These tumour markers are not diagnostic on their own but they establish baselines and flag unexpected elevations for further investigation. The NHS does not include any tumour markers in routine screening blood tests.
The TrueVitals Ultimate panel covers advanced cardiovascular markers (ApoB, Lp(a)), full metabolic profiling (fasting insulin, HOMA-IR), complete hormonal panel, full thyroid with antibodies, tumour markers, and 100+ additional biomarkers. 114 markers. Results in 48 hours. £349.
A single blood test gives you a snapshot. Two tests, a decade apart, give you a trajectory. That trajectory is where the most important clinical decisions live.
An ApoB of 1.1 g/L at 50 is elevated. But was it 0.9 at 40 (slow progression, lifestyle adjustable) or 1.4 at 40 (actually improving, keep doing what you're doing)? A testosterone of 12 nmol/L at 50 is borderline. But was it 18 at 40 (33% decline, potentially warranting investigation) or 13 at 40 (minimal change, probably fine)? A ferritin of 40 at 50 is "in range." But was it 90 at 40 (halved in a decade, something is depleting your iron)?
These comparisons are impossible without the earlier data point. Every marker becomes more meaningful with context, and the context is time.
If you didn't test at 40, test now. The 50-year-old baseline is your reference point for 55, 60, and beyond. The best time to start was a decade ago. The second-best time is today.
These are the marker groups that matter most at 50, grouped by the risk they assess.
Total cholesterol, LDL, HDL, triglycerides, ApoB, Lp(a), homocysteine, hs-CRP, non-HDL
HbA1c, fasting glucose, fasting insulin, HOMA-IR, C-peptide, fructosamine
Testosterone, SHBG, free T, oestradiol, FSH, LH, prolactin, cortisol, DHEA-S, progesterone
TSH, Free T4, Free T3, Anti-TPO, Anti-Tg
PSA (men), CA-125 (women), CEA, CA 19-9, CA 15-3 (women)
Full liver panel (ALT, AST, GGT, ALP, bilirubin, albumin), full kidney (creatinine, eGFR, urea, uric acid, cystatin C)
Vitamin D, B12, folate, ferritin, transferrin saturation, zinc
FBC, hs-CRP, ESR, IgA, IgG, IgM
The TrueVitals Ultimate panel includes every marker group listed above across 114 biomarkers. The Signature panel extends to 200+ biomarkers via Randox for maximum depth, including extended autoimmune and allergy markers.
At 50, a list of individual marker values is not useful. You need pattern recognition. Elevated ApoB alongside rising fasting insulin alongside declining testosterone is a specific metabolic-cardiovascular pattern that tells a story and demands a specific response. An AI cross-system analysis identifies these patterns, explains them in plain English, and provides targeted recommendations. A medical professional reviews every report before it reaches you. The result is a clinical-grade document you can take to your GP, cardiologist, or endocrinologist and use to have a data-driven conversation about your health trajectory.
114 biomarkers. Cardiovascular, metabolic, hormonal, thyroid, and cancer screening markers. AI cross-system analysis. Medical review. Results in 48 hours.
.png)